ODI — Odi Pharma AB (publ) Share News
0.000.00%
- SEK46.93m
- SEK42.74m
- SEK3.13m
Brief: ODI Pharma Reports Revised Qtrly Result Per Share Amounted To SEK -0.09 (-0.05)
Brief: ODI Pharma Says Group's Net Sales For Q2 Amounted To Sek 458,620
Brief: ODI Pharma Says Group's Net Sales For Q3 Amounted To SEK 0 (SEK 1,567)
Brief: ODI Pharma Q2 Loss After Financial Items Narrows To SEK 0.8 Mln
Brief: ODI Pharma Says Its Unit Applied For Marketing Authorization For Sale Of Medicinal Cannabis With Polish Health Agency
Brief: ODI Pharma Proceeds With Its Plans And Launches Project Skin
Brief: Odi Pharma Q1 Pretax Loss Widens To SEK 1.3 Mln
Brief: Odi Pharma AB (publ) Investigating Expansion Into Skin Care Products Business
Brief: ODI Pharma AB And Aphria Inc. Execute Supply Agreement
Brief: OdiPharma And Aphria Execute Supply Agreement
Brief: Odi Pharma Qtrly Loss Per Share Amounted To SEK 0.08
Brief: ODI Pharma Q3 Pretax Loss At SEK 1.7 Mln
Brief: Odi Pharma Says Co Does Not See Any Impact On Mid- And Long-Term Goals Following Covid-19